Differences in the pharmacokinetics of Cyp3a substrates in TSOD and streptozotocin-induced diabetic mice

References

• Adithan C, Danda D, Shashindran CH, Bapna JS, Swaminathan RP, Chandrasekar S. (1989). Differential effect of type I and type II diabetes mellitus on antipyrine elimination. Meth Find Exp Clin Pharmacol 11:755–8.
   Google Scholar
• Dong B, Qatanani M, Moore DD. (2009). CAR mediates the induction of drug metabolism in mouse models of type 1 diabetes. Hepatology 50:662–9.
   Google Scholar
• Hukkinen SK, Varhe A, Olkkola KT, Neuvonen PJ. (1995). Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice. Clin Pharmacol Ther 58:127–31.
   PubMed Web of Science ®Google Scholar
• Iizuka S, Suzuki W, Tabuchi M, Nagata M, Imamura S, Kobayashi Y, Kanitani M, Yanagisawa T, Kase Y, Takeda S, Aburada M, Takahashi KW. (2005). Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity. Exp Anim 54:71–83.
   PubMed Web of Science ®Google Scholar
• Jetter A, Kinzig-Schippers M, Walchner-Bonjean M, Hering U, Bulitta J, Schreiner P, Sörgel F, Fuhr U. (2002). Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clin Pharmacol Ther 71:21–9.
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Walker A, Hoffer C, Sheffels P. (2004). Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis. Clin Pharmacol Ther 76:452–66.
   PubMed Web of Science ®Google Scholar
• Kudo T, Shimada T, Toda T, Igeta S, Suzuki W, Ikarashi N, Ochiai W, Ito K, Aburada M, Sugiyama K. (2009). Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity. Xenobiotica 39:889–902.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–5.
   PubMed Web of Science ®Google Scholar
• Levert KL, Waldrop GL, Stephens JM. 2002. A biotin analog inhibits acetyl-CoA carboxylase activity and adipogenesis. J Biol Chem 277:16347–50.
   PubMed Web of Science ®Google Scholar
• Lilja JJ, Kivistö KT, Neuvonen PJ. (1998). Grapefruit juice–simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Clin Pharmacol Ther 64:477–83.
   PubMed Web of Science ®Google Scholar
• Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, Watkins PB. (1997). Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99:2545–53.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. (1951). Protein measurement with the Folin phenol regent. J Biol Chem 193:265–75.
   PubMed Web of Science ®Google Scholar
• Marques MP, Coelho EB, Dos Santos NA, Geleilete TJ, Lanchote VL. (2002). Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus. Eur J Clin Pharmacol 58:607–14.
   PubMed Web of Science ®Google Scholar
• Matzke GR, Frye RF, Early JJ, Straka RJ, Carson SW. (2000). Evaluation of the influence of diabetes mellitus on antipyrine metabolism and CYP1A2 and CYP2D6 activity. Pharmacotherapy 20:182–90.
   PubMed Web of Science ®Google Scholar
• Miura T, Suzuki W, Ishihara E, Arai I, Ishida H, Seino Y, Tanigawa K. (2001). Impairment of insulin-stimulated GLUT4 translocation in skeletal muscle and adipose tissue in the Tsumura Suzuki obese diabetic mouse: a new genetic animal model of type 2 diabetes. Eur J Endocrinol 145:785–90.
   PubMed Web of Science ®Google Scholar
• Mizutani S, Gomi H, Hirayama I, Izumi T. (2006). Chromosome 2 locus Nidd5 has a potent effect on adiposity in the TSOD mouse. Mamm Genome 17:375–84.
   Google Scholar
• Nakashima K, Yamamoto K, Al-Dirbashi OY, Nakashima MN. (2002). Expression profile of liver genes in response to hepatotoxicants identified using a SAGE - based customized DNA microarray system. Biomed Chromatogr 16:219–23.
   Google Scholar
• Perloff MD, von Moltke LL, Court MH, Kotegawa T, Shader RI, Greenblatt DJ. (2000). Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms. J Pharmacol Exp Ther 292:618–28.
   PubMed Web of Science ®Google Scholar
• Rogers JD, Zhao J, Liu L, Amin RD, Gagliano KD, Porras AG, Blum RA, Wilson MF, Stepanavage M, Vega JM. (1999). Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Clin Pharmacol Ther 66:358–66.
   PubMed Web of Science ®Google Scholar
• Sakuma T, Honma R, Maguchi S, Tamaki H, Nemoto N. (2001). Different expression of hepatic and renal cytochrome P450s between the streptozotocin-induced diabetic mouse and rat. Xenobiotica 31:223–37.
   PubMed Web of Science ®Google Scholar
• Sotaniemi EA, Pelkonen O, Arranto AJ, Tapanainen P, Rautio A, Pasanen M. (2002). Diabetes and elimination of antipyrine in man: an analysis of 298 patients classified by type of diabetes, age, sex, duration of disease and liver involvement. Pharmacol Toxicol 90:115–60.
   Google Scholar
• Suzuki W, Iizuka S, Tabuchi M, Funo S, Yanagisawa T, Kimura M, Sato T, Endo T, Kawamura H. (1999). A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim 48:181–9.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Tabuchi M, Suzuki W, Iizuka S, Nagata M, Ikeya Y, Takeda S, Shimada T, Aburada M. (2006). Insulin resistance and low sympathetic nerve activity in the Tsumura Suzuki obese diabetic mouse: a new model of spontaneous type 2 diabetes mellitus and obesity. Metabolism 55:1664–9.
   Google Scholar
• van Herwaarden AE, Wagenaar E, van der Kruijssen CM, van Waterschoot RA, Smit JW, Song JY, van der Valk MA, van Tellingen O, van der Hoorn JW, Rosing H, Beijnen JH, Schinkel AH. (2007). Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. J Clin Invest 117:3583–92.
   Google Scholar
• Woodcroft KJ, Novak RF. (1997). Insulin effects on CYP2E1, 2B, 3A, and 4A expression in primary cultured rat hepatocytes. Chem Biol Interact 107:75–91.
   PubMedGoogle Scholar
• Woodcroft KJ, Novak RF. (1999). Insulin differentially affects xenobiotic-enhanced, cytochrome P-450 (CYP)2E1, CYP2B, CYP3A, and CYP4A expression in primary cultured rat hepatocytes. J Pharmacol Exp Ther 289:1121–7.
   PubMedGoogle Scholar
• Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. (1981). A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879–85.
   PubMedGoogle Scholar
• Zysset T, Wietholtz H. (1988). Differential effect of type I and type II diabetes on antipyrine disposition in man. Eur J Clin Pharmacol 34:369–75.
   Google Scholar
• Zysset T, Wietholtz H. (1991). Pharmacokinetics of caffeine in patients with decompensated type I and type II diabetes mellitus. Eur J Clin Pharmacol 41:449–52.
   Google Scholar